Authorities in Shenzhen are reportedly scrutinising gene-editing trials for the first time, including those using CRISPR technology, amid mounting concerns about a lack of regulatory oversight. Reports of clinical studies which have not kept in touch with participants, and the death of a clinical trial patient that was not investigated have reportedly alarmed Western scientists. Beijing 's science ministry has now requested its first -ever report about a trial, run by Anhui Kedgene Biotechnology . The moves come after the claim in the last few years that a China -based scientist had used Crispr-Cas9 to create the world’s first gene-edited babies, prompting international outrage.
Authorities in Beijing are reportedly scrutinising gene-editing trials for the first time, including those using CRISPR technology, amid mounting concerns about a lack of regulatory oversight. Reports of clinical studies which have not kept in touch with participants, and the death of a clinical trial patient that was not investigated have reportedly alarmed Western scientists. China's science ministry has now requested its first-ever report about a trial, run by Anhui Kedgene Biotechnology. The moves come after the claim in December that a Shenzhen-based scientist had used CRISPR to create the world’s first gene-edited babies, prompting international outrage.